Research Opportunities
We want to help kidney cancer researchers locate funding opportunities. We’ll update this page with grant opportunities as we learn about them. Know of one we haven’t listed? Email us at [email protected], or tweet at us, and we’ll get it posted!
KidneyCAN is dedicated to accelerating kidney cancer research.
Our advocacy for the DoD Kidney Cancer Research Program resulted in appropriations of $40 million in fiscal year 2020 for kidney cancer research. In 2016, this number was $0.
Our Kidney Cancer Research Summit brings translational researchers in kidney cancer together in an annual collaborative meeting. Additionally, KidneyCAN’s “Rock the Cure” events have raised over $1,000,000 toward private research support.
We are reaching out to you to create the best ideas yet for your KCRP proposal this year.
Please share this notice with other researchers in your network.
- Develop your ideas
- Build your team – even including members from other institutions
- Gather letters of support
- Review the grant mechanisms (including the new ones) and consider which would best support your idea
- Consider partnerships (including industry partnerships) and collaborations
FY21 KCRP Program Announcements Released
As new announcements are posted we will keep you updated.
Translational Research Partnership Award
Idea Development Award
Postdoctoral and Clinical Fellowship Award
AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants
The AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants represents a joint effort to stimulate “high-risk, high-reward” research from early- to mid-career investigators. This novel grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that might not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries that will advance our understanding of cancer and have a potentially transformative impact on future clinical practice.
The application is due on September 30, 2021.
AACR: New Funding Opportunities
We’d love to see more RCC applicants for these prestigious grant opportunities. AACR has just updated their site with this note:
We hope you and your loved ones are well, given the difficult circumstances surrounding the COVID-19 pandemic. Please note that several funding opportunities are currently under development. Although we expect that the process may likely take longer than originally expected, please know that our team is working diligently to ensure that the new grants will be launched at the earliest possible date. We are closely monitoring the situation and will post upcoming funding opportunities here once a launch date has been confirmed.
However, if you have specific questions or concerns, please feel free to contact [email protected].
Sincerely,
The Scientific Review and Grants Administration Team
KidneyCAN is proud to present the 3rd Annual Kidney Cancer Research Summit on October 7 & 8, 2021. KCRS is a meeting focused on basic, translational, and clinical kidney cancer research. This meeting is fueled by the ideas and research funded through the Department of Defense CDMRP-KCRP awards.
The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.
Kidney cancer is the ideal sandbox for these new approaches, and without a doubt the same approach can, should and will be suitable for other cancers.
Dr. Hans Hammers, UTSW
RESEARCH UPDATES
IKCC Report: Retention in Clinical Trials
The International Kidney Cancer Coalition launched a pilot program to understand the barriers and other considerations that drive the decision to leave a clinical trial and uncover ways to better support patients currently in or considering joining clinical trials....
Let’s Get Loud: Spring 2022 Advocacy Days
On March 7-8, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and...
Fall Micro-Strike: KidneyCAN Asks Congress to Fund Kidney Cancer Research
Fall Micro-Strike: KidneyCAN Asks Congress to Fund Kidney Cancer ResearchOn Monday, December 1, 2021, KidneyCAN gathered a team of delegates and once again asked Congress to fund kidney cancer research. We are asking for robust funding of the Congressionally Directed...
Join Our Grassroots Army
;
ICYMI: @montypal, of @cityofhope, discusses research presented at #GU22, including data from TIVO-3 & findings from NeoAvAx exploring avelumab plus axitinib for patients w/ high-risk, nonmetastatic clear-cell RCC in a recent episode of #OncLiveOnAir #kcsm http://ow.ly/skTo50Jcv7v
Lets get people talking about “access to treatments for kidney cancer patients “ Join us on 16th June 2022 and raise awareness of the inequities faced by kidney cancer patients around the world #WKCD2022 #kidneycancer https://ikcc.org/world-kidney-cancer-day/
Celebrating clinical trial day! Clinical research is the only way to improve care! Thank you everyone who strives to push this effort @eaonc @BigTenCRC @PennStHershey @jlkrasch @PGrivasMDPhD @shilpaonc @ASCOPost
Exciting results with unconventional cabo dose increase may offer hope for stage 4 #kidneycancer patients in need of treatment options; @KCPUTSW partnering with @ExelixisInc to explore clinical trial. @utswcancer
https://content.iospress.com/articles/kidney-cancer/kca210117
https://kcp.utsw.edu/utsw-newsroom/higher-doses-of-kidney-cancer-drug-may-offer-hope-to-metastatic-patients/
For this installment of #KidneyCANDID, @montypal of @cityofhope shares 2 things patients can do as they prepare for their #kidneycancer appointments.
Questions & Support: What to Bring to Your Kidney Cancer Oncology Appoin... via @YouTube
@OncoAlert
Save the date 16 June 2022 to take part in World Kidney Cancer Day and raise awareness of clinical trials and access to treatments for #kidneycancer patients.
To improve the lives of patients worldwide ‘We need to talk’.
For more info:
https://actionkidneycancer.org/get-involved/wold-kidney-cancer-day/
WATCH: @BraunMDPhD, of @YaleCancer, explains how biomarkers help to stratify treatment decision-making for patients with RCC. #kcsm #oncology http://ow.ly/Mzsp50JbmTX
So much to look forward to at @ASCO #ASCO22 #ASCOGU. Thank you @DrChoueiri for this excellent roundup!
As #ASCO22 is approaching, my top 10 GU abstracts to be presented (just based on titles!). This is not an exhaustive list with many more exciting abstracts to discover…
@ASCO @OncoAlert @ASCOPres @CliffordHudis @jrgralow @DanaFarber_GU
4-CALYPSO: A three-arm randomized phase II study of durvalumab alone or with savolitinib or tremelimumab in previously treated advanced clear cell renal cancer.
@tompowles1 | @QMBCI
